Home Biosimilar Antibodies Others Others antibody Lirentelimab (Anti-Siglec-8) For research use only.
Not for use in humans.

Lirentelimab (Anti-Siglec-8)

Synonyms: AK002

Lirentelimab (Anti-Siglec-8) is a humanized IgG1 monoclonal antibody that targets sialic acid-binding Ig-like lectin 8 (SIGLEC8). It can be used for the research of eosinophilic gastritis and duodenitis. MW :150 KD.

Lirentelimab (Anti-Siglec-8)

Purity & Quality Control

Batch: A261901 Purity: 99% Protein concentration: 8.99mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Lirentelimab (Anti-Siglec-8) is a humanized IgG1 monoclonal antibody that targets sialic acid-binding Ig-like lectin 8 (SIGLEC8). It can be used for the research of eosinophilic gastritis and duodenitis. MW :150 KD.

Product Details

CAS No. 2283348-97-8
Molecular Weight 150
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Lirentelimab (Anti-Siglec-8) | Lirentelimab (Anti-Siglec-8) supplier | purchase Lirentelimab (Anti-Siglec-8) | Lirentelimab (Anti-Siglec-8) cost | Lirentelimab (Anti-Siglec-8) manufacturer | order Lirentelimab (Anti-Siglec-8) | Lirentelimab (Anti-Siglec-8) distributor